Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990

Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990

  • FF launched four Industry Productivity Solutions across K-12 Education, Research, Security and Inspection, helping customers reduce deployment and adoption barriers and providing industries with replicable paths to practical robot applications aiming to deliver the industry’s highest-ROI solutions.

  • FF launched nine new EAI Device configurations across two robot forms, three product series and five models: FF All-New Futurist, FF Master Mini, FX Aegis Hyper, FX Aegis Mega and FX Aegis Classic Ultra-W. All nine products are now available for sale and delivery.

  • FF aims to build the world’s only “One-Brain Multi-Form Multi-Capability” FF EAI Robot World, with Version 2.0 now complete. FF believes it has become the U.S. robotics company with the most complete range of robot forms, the broadest size coverage and the largest number of robot models.

  • FF has established a “Light on Four, Heavy on Four” operating model, remaining light on capital, assets, marketing and sales while focusing on product strength, AI, real-world utility and users to improve the efficiency of strategy execution. Based on the Company’s Q2 financial results, the average contribution margin on its robotics products reached approximately 30%.

  • FF Master Mini starts at $9,990 and is North America’s first compact EAI humanoid robot priced below $10,000 to combine programming education, open development and sports competition. Both FX Aegis Mega configurations are priced at $74,990 and offer exceptional value among mid-sized industrial robot dogs in the U.S. market. FF’s goal is to combine “the lowest price, four-core value and ongoing service” in a complete, high-value “Four-Core Full-Stack AI” EAI ecosystem.

  • FF has established its “6+1” FF EAI Robotics Direct Sales and Robot-Sharing Rental Network, with six routes to market: B2B, FF Par, E-commerce, Marcom & Video Sales, Community and Mcube. RoboShare provides additional options for rentals and asset onboarding.

  • RoboShare, the robot-sharing and rental platform of AIxC which is majority-owned and controlled by FF, has signed an MOU with Hifivebot, a U.S. robot rental platform. RoboShare is also evaluating an expansion of its existing network into additional AI device categories, including autonomous shared mobility, to explore broader Physical AI asset-sharing services.

  • FF plans to hold an FF EAI Robotics partnership launch in the Middle East with local partners on September 23. On September 28, FF plans to hold Part Two of the FF EAI Robotics “Built in USA” Launch and Business Partner Conference. FF will also participate in IROS 2026 in Pittsburgh from September 28 through September 30.

LOS ANGELES–(BUSINESS WIRE)–
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today held its 919 FF EAI Robotics “Four-Core Full-Stack AI” Ecosystem New Product Series Launch. FF unveiled 9 new EAI Device configurations across five models which included its FF All-New Futurist, FF Master Mini, FX Aegis Hyper, FX Aegis Mega and FX Aegis Classic Ultra-W. FF also launched 4 Industry Productivity Solutions for K-12 Education, Research, Security and Inspection. FF’s “Four-Core Full-Stack AI” open ecosystem comprises the EAI Brain and Developer Platform, EAI Devices, Industry Productivity Solutions and the EAI Data Factory. The event highlighted the latest product and application developments across the EAI Devices and Industry Productivity Solutions cores.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260919657129/en/

Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990

Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990

A video of the event can be viewed here: https://youtu.be/0KZGgyrsUcU

“FF is not building a single robot form that attempts to do everything, we are building a robotics ecosystem in which a generalized and adaptable EAI Brain supports multiple robot forms,” said YT Jia, Founder and Global CEO of FF. “Our approach aligns with renowned AI scientist and Stanford professor Dr. Fei-Fei Li’s view that multiple robot forms will coexist within one ecosystem. These robot forms not only address a wider range of tasks but also generate real-world data from diverse scenarios and interactions. Through the EAI Data Factory, that data supports EAI Brain training, Skills development and EAI Device iteration, enabling robot forms and capabilities to evolve together.”

Five Models and Nine New EAI Devices Complete FF’s EAI Robot World 2.0

The nine new EAI Device configurations span two robot forms, humanoid and quadruped, and three product series.

FF All-New Futurist is positioned as a flagship, full-size professional EAI humanoid robot and an “All-in-One Professional Expert.” It has 51 active degrees of freedom, increasing to 71 with an advanced dexterous-hand upgrade. Its 1,152-watt-hour dual-battery system supports approximately eight hours of operation under standard working conditions, along with autonomous charging. The Ultra version is powered by NVIDIA Jetson Thor and delivers 700 TOPS of computing power. Combined with VLA, world models, and task planning, it can move beyond executing individual commands to complete entire tasks. The product is designed for university research, embodied AI development, enterprise services, sports competition, and industrial applications. The FF All-New Futurist Standard is priced at $89,900 and includes a Skills Package valued at $10,000. The FF All-New Futurist Ultra is priced at $129,900 and includes a Skills Package valued at $15,000.

The FF Master Mini including three configurations, Master Mini, Master Mini Pro, and Master Mini Ultra, is positioned as an EAI humanoid robot for education, sports and robotics competition, serving as an all-rounder “from classroom to competition.” It stands approximately 95 centimeters tall and weighs approximately 19.5 kilograms. Its three configurations provide 48, 117, and 200 TOPS of computing power, respectively. Open motion, perception and application interfaces support programming education, open development, entertainment performances, and robot soccer competitions. The Master Mini series starts at $9,990 and includes a Skills Package valued at $1,000. The Pro version is priced at $12,990 and includes a Skills Package valued at $1,500. The Ultra version is priced at $17,990 and includes a Skills Package valued at $2,000.

FX Aegis Hyper is a large industrial-grade EAI quadruped designed for extreme environments, heavy-duty tasks and high-risk autonomous operations, with support for professional payloads including thermal imaging, gas detection, 3D scanning and communications relay equipment. The Aegis Hyper starts at $137,900 and includes a Skills Package valued at $15,000.

FX Aegis Mega, available in two configurations, is mid-sized industrial-grade wheel-legged EAI robots with a maximum payload capacity of 50 kilograms. They can continuously climb 25-centimeter stairs and clear single obstacles up to 80 centimeters, while hot-swappable dual batteries provide at least five hours of unloaded runtime. The Aegis Mega starts at $74,990, including an $8,000 Skills Package.

FX Aegis Classic Ultra-W is a lightweight professional wheel-legged EAI robot for security and companionship. Its approximately 22-kilogram body combines wheeled mobility, legged obstacle-clearing capability, low-noise operation and open development, with support for secondary development, simulation training, multi-robot coordination and professional payload expansion. The Aegis Classic Ultra-W is priced at $12,990, including a $3,000 Skills Package.

With the launch of these nine new configurations, FF EAI Robot World has officially been upgraded to Version 2.0. The portfolio now covers three robot forms, humanoid, quadruped and mobile manipulator; five product series, Futurist, Master, Aegis, Navi and Faber; 11 models; and 24 products.

Four Industry Productivity Solutions and FF EAI Robotics Education & Research Ecosystem 1.0

FF launched four EAI Robotics Industry Productivity Solutions for K-12 Education, Research, Security and Inspection. The K-12 Education and Research Solutions together form the FF EAI Robotics Education & Research Ecosystem 1.0. The Security and Inspection Solutions address communities, buildings, industrial parks, energy, electric power, manufacturing, mining, tunnels and large facilities. With the four Industry Productivity Solutions, FF aims to offer solution pricing designed with the highest ROI in the industry, further lowering deployment and adoption barriers for customers.

The FF EAI Robotics K-12 Education Solution is an integrated Physical AI teaching and competition growth platform for K-12 students. Centered on Master Mini, the solution brings together Navi, Aegis, Master and All-New Futurist to support different stages, from early learning through advanced high-school education and university research. The platform provides a three-tier curriculum in Blockly, Python and ROS, together with a supporting competition system covering early interest, programming, AI practice, robot competition and the progression to research and higher education. The solution also includes robots and development kits, grade-specific courses, teaching and learning platforms, a developer platform, teacher training, classroom and competition projects, device and classroom management, learning assessment, data security and technical support. It provides modular support for K-12 private schools, public schools and school districts, and training institutions.

The FF EAI Robotics Research Solution is a Physical AI teaching and embodied AI research platform for universities that spans multiple robot forms. Led by All-New Futurist, it brings together Master, Master Mini, Aegis Classic, Aegis Mega and Faber. The platform provides a unified SDK, ROS interfaces, simulation and digital twins, data collection, model training and Skill management. It supports research in motion control, embodied foundation models, Sim-to-Real and swarm intelligence, enabling research teams to complete algorithm development, simulation validation, physical robot deployment and cross-device migration within a unified tool chain.

The FF EAI Robotics Security Solution uses a tiered, multi-model deployment approach. The Aegis Classic handles indoor and building patrols, while Aegis Mega handles large outdoor and high-risk tasks. Professional payloads can include thermal imaging, 360-degree cameras and LiDAR. The platform supports multi-robot management, autonomous patrols, multimodal sensing, AI event recognition, alarm integration, remote operation and evidence archiving across communities, campuses, industrial parks, warehouses and critical infrastructure.

The FF EAI Robotics Inspection Solution is designed for energy, electric power, manufacturing, mining, tunnels and large facilities. Aegis Mega handles high-frequency inspections at large industrial parks and power stations, Aegis Hyper operates in extreme and high-risk areas, and Faber performs precision indoor operations. The system supports PTZ cameras, thermal imaging, gas detection, 3D scanning and robotic-arm end effectors. The FF Smart Inspection Platform provides autonomous mapping, meter OCR, anomaly and leak detection, report generation, alerts and work-order management.

Within the “Four-Core Full-Stack AI” open ecosystem, partners can connect with EAI Devices across different robot forms and contribute professional payloads, algorithms, Skills, data and scenario capabilities to jointly develop Industry Productivity Solutions for different sectors.

Sales and Delivery Begin Today; FF Establishes a Unique “6+1” Direct Sales and Robot-Sharing Rental Network

FF offers three product packages: a standard EAI Device, an EAI Device + Skills Package, and an EAI Device + Complete Solution. The Company has also established its “6+1” FF EAI Robotics Direct Sales and Robot-Sharing Rental Network, which means it offers six different routes to market including B2B, FF Par, E-commerce, Marcom & Video Sales, Community and Mcube. Each one covers different customers and sales touchpoints and connects with FF’s unified systems for orders, delivery, pricing and after-sales support. RoboShare, a robot-sharing and operations platform operated by AIxC, which is majority-owned by FF, provides on-demand robot rentals and asset onboarding for eligible devices, further connecting product sales, channel partnerships, asset operations and real-world deployment.

All products are now available for sale and delivery. Customers can place orders through FF.com, Amazon, and RobotShop. Additional product details, including compliance information, are available on FF.com.

ABOUT FARADAY FUTURE

Founded in 2014, Faraday Future (FF) is a U.S.-based Physical AI ecosystem company dedicated to reshaping the future of robotics and mobility solutions through AI innovation and technologies. FF focuses on two major product strategies within the Embodied AI (EAI) robotics business: EAI humanoid and bionic robots, and EAI automotive-focused robots. By building a “Four-Core Full-Stack AI” ecosystem comprising the EAI Brain and Developer Platform, EAI Devices, Industry Productivity Solutions and the EAI Data Factory, FF aims to create an evolutionary flywheel: scaled device delivery, data collection and training, continuous evolution of the EAI Brain, stronger product capabilities, and even larger-scale delivery and deployment. Through this flywheel, FF seeks to maximize its commercial value and advance the development of Physical AI.

For more information, please visit Faraday Future’s official website: https://www.ff.com/

FORWARD LOOKING STATEMENTS

This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding Faraday Future Intelligent Electric Inc.’s (the “Company’s”) “Bridge Strategy,” the Company’s growth strategy, fundraising activities and prospects, the development of markets in which the Company operates or seeks to operate, the production and delivery of the FF 91, the Faraday X (FX) brand, and future compliance with Nasdaq listing requirements, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. These forward-looking statements speak only as of the date of this press release, and the Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Important factors that may affect actual results or outcomes include, among others: the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations, which it currently lacks; the availability of sufficient share capital to meet its current obligations and execute on its strategy; the willingness of convertible debt investors to fund the Company; demand for the Company’s robotics products; the ability of B2B preorder companies to locate customers to purchase our robotics products, on which their nonbinding preorders substantially depend; competition in the robotics industry, which includes companies with far superior experience, funding and name recognition; the ability of the Company to build an EAI education ecosystem that serves both the B2C consumer market and the B2B institutional education market; the acceptance by teachers and students of the Company’s robotics products in the education market; the ability of the Company to expand into additional markets for its robotics products; the Company’s reliance on a single OEM for most of its robotics products; the Company’s reliance on Chinese OEMs for all of its robotics products; the possibility of the federal government banning imports of Chinese robotics products; the Company’s ability to get the planned robotics products to comply with all applicable U.S. rules and regulations; the ability of the robotics OEM to timely supply robotics to the Company; tariff uncertainty for imported products, particularly from China; demand from automobile dealers for robotics products; the Company’s ability to homologate FX vehicles for sale; the Company’s ability to secure the necessary funding to execute on the FX strategy, which is substantial; the Company’s ability to secure an occupancy certificate covering all of its Hanford facility; the Company’s ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of substantial losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company’s control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company’s operations in China; the success of the Company’s remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company’s ability to develop and protect its technologies; the Company’s ability to protect against cybersecurity risks; the Company’s ability to attract and retain employees; any adverse developments in existing legal proceedings or the initiation of new legal proceedings; and volatility of the Company’s stock price.

You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on August 13, 2026; the Company’s Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 14, 2026; the Company’s Form 10-K filed with the SEC on March 31, 2026; and other documents filed by the Company from time to time with the SEC.

Investors (English): [email protected]

Investors (Chinese): [email protected]

Media: [email protected]

KEYWORDS: China United States North America Asia Pacific California

INDUSTRY KEYWORDS: Robotics Education Technology Manufacturing Other Technology Other Education Other Manufacturing

MEDIA:

Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FX Aegis Mega Shown)
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FX Aegis Classic Ultra-W Shown)
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FX Aegis Mega Shown)
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FX Aegis Hyper Shown)
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FF All-New Futurist Shown)
Photo
Photo
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now on Sale and Master Mini Starts at $9,990 – (FF Master Mini Shown)
Logo
Logo

CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law

CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cellectis S.A. (“Cellectis” or “the Company”) (NASDAQ: CLLS) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cellectis announced on September 14, 2026, that it would prioritize in vivo gene editing therapies over CAR-T cell therapies. The Company also announced the discontinuation of development of certain CAR-T cell therapies. The Company’s Chief Medical Officer stated, “Cellectis is not able finance [Eti-cel and Lasme-cel] given the time lines that we have and the limited cash resources that we have.” Based on this news, shares of Cellectis fell by almost 41% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

SEDG Investors Have Opportunity to Join SolarEdge Technologies, Inc. Fraud Investigation with SBS Law

SEDG Investors Have Opportunity to Join SolarEdge Technologies, Inc. Fraud Investigation with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or “the Company”) (NASDAQ: SEDG) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. SolarEdge released its financial results for Q2 2026 on August 5, 2026. The Company forecasted Q3 revenues that fell short of analyst estimates. Based on this news, shares of SolarEdge fell by almost 30.5% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

KLAR Investors Have Opportunity to Join Klarna Group plc Fraud Investigation with SBS Law

KLAR Investors Have Opportunity to Join Klarna Group plc Fraud Investigation with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Klarna Group plc (“Klarna” or “the Company”) (NYSE: KLAR) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Klarna released its financial results for Q2 2026 on August 18, 2026. The Company significantly lowered its full-year 2026 revenue forecast. The Company also announced the departure of its CFO and CMO in early 2027. Based on this news shares of Klarna fell by more than 22.8% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

BBW Investors Have Opportunity to Join Build-A-Bear Workshop, Inc. Fraud Investigation with SBS Law

BBW Investors Have Opportunity to Join Build-A-Bear Workshop, Inc. Fraud Investigation with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Build-A-Bear Workshop, Inc. (“Build-A-Bear” or “the Company”) (NYSE: BBW) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

DNOW 13-DAY DEADLINE ALERT: DNOW Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 2, 2026 Lead Plaintiff Deadline

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman encourages investors in DNOW Inc. (NYSE: DNOW) who suffered substantial losses submit your losses now. A securities class action lawsuit has been filed regarding potential violations of federal securities laws involving DNOW’s acquisition of MRC Global Inc. and undisclosed enterprise software integration failures in the merger proxy materials.

  • Lead Plaintiff Deadline: Oct. 2, 2026
  • Defined Investor Class and Record Date: Shareholders who held DNOW common stock as of the August 5, 2025 record date and were thus entitled to vote at DNOW’s September 9, 2025 special meeting on the merger of DNOW and MRC Global

Investors with significant losses are urged to contact the firm to review their options:

Allegedly Misleading Proxy Materials:

The suit alleges that the Proxy Materials misrepresented and omitted to disclose challenges posed with DNOW’s merger with MRC Global Inc. as a result of material issues affecting MRC Global’s new ERP system.

The Truth Allegedly Emerges

  • November 5, 2025 — Reassurances Before Acquisition: The complaint alleges that on DNOW’s Q3 2025 earnings call—the day before closing the merger—management assured investors that MRC Global had implemented a “state-of-the-art” Enterprise Resource Planning (ERP) system that promised “improved inventory management, order processing efficiency, and supply chain optimization.” DNOW allegedly minimized integration risks, reassuring the market that MRC’s past software glitches were merely an “isolated, one-time event.”
  • February 20, 2026 — The Disclosures: DNOW reported its Q4 and full-year 2025 financial results, revealing that MRC revenues had sharply declined due to “persistent ERP challenges” and acknowledging that MRC’s software implementation was, in fact, an “obstacle.
  • Operational Flaws & Guidance Delay: Management conceded that flawed software design architecture caused severe operational slowdowns, impeded customer service, and required substantial unexpected capital expenditure to remediate. Consequently, DNOW was forced to delay its sequential and full-year 2026 financial guidance.
  • Market Impact: On this news, DNOW stock crashed 19% in a single trading session.

Statement from Hagens Berman Partner Reed Kathrein

“We are focused on whether the Proxy Materials downplayed ERP integration failures at MRC Global allowing management to push the deal through, as the complaint alleges,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation of the claims in the pending suit.

What DNOW Investors & Whistleblowers Can Do

  • DNOW Investors: If you purchased DNOW common stock and sustained significant losses, you may be eligible to take an active role in the class action. The court-appointed lead plaintiff deadline is October 2, 2026.Submit your loss details here.

  • Whistleblowers: Persons with non-public information regarding DNOW should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]



PNR 13-DAY DEADLINE ALERT: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 2, 2026 Lead Plaintiff Deadline

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) — Hagens Berman Sobol Shapiro LLP alerts investors in Pentair plc (NYSE: PNR) that a securities fraud class action lawsuit filed against the company has been expanded to cover an earlier class period. Investors who suffered substantial losses are urged to submit their losses now.

CASE DETAILS

Expanded Class Period: March 11, 2025 – July 14, 2026 (Previously April 28, 2026 – July 14, 2026)
Lead Plaintiff Deadline: Oct. 2, 2026
Contact Hagens Berman: Visit www.hbsslaw.com/pnr, email [email protected], or call (844) 916-0895

ALLEGED MISCONDUCT & EXPANDED CLASS PERIOD

The new class action lawsuit alleges that beginning on March 11, 2025, Pentair plc and certain of its top executives made a series of materially false and misleading statements and omitted critical adverse operational information regarding Pentair’s financial health, channel inventory, and internal controls.

Specifically, the lawsuit alleges Defendants failed to disclose that:

  1. Pentair was experiencing severe, undisclosed channel inventory destocking—particularly within its core Pool segment.
  2. The company engaged in unsustainable channel-loading and sales practices with distributors to artificially inflate short-term financial metrics.
  3. As a result, Pentair’s positive statements regarding its business, full-year financial guidance, and operating income lacked a reasonable basis.

THE DISCLOSURE & MARKET REACTION

The complaint alleges that the artificial inflation in Pentair shares came to an abrupt end on July 14, 2026, after the market closed, when Pentair shocked investors by pre-announcing preliminary second-quarter 2026 financial results that fell substantially below consensus estimates.

The disclosures revealed severe operational headwinds:

  • Massive Revenue Miss: Sales were expected to be approximately $930 million—a drastic miss against prior forecasts of $1.14 billion. The company disclosed that inventory destocking in the Pool channel negatively impacted Pool segment sales by approximately $170 million and income by approximately $105 million.
  • Full-Year Guidance Slashed: Pentair dramatically cut its full-year 2026 outlook, reversing earlier projections. Full-year sales were projected to be down approximately 4% to 7%, compared to prior guidance of up 2% to 4% growth.
  • Abrupt CFO Departure: Compounding the shock, Pentair announced the immediate departure of its Chief Financial Officer, Nicholas Brazis, after serving in the role for only four months, raising questions regarding internal controls and financial reporting.

Following these disclosures, Pentair’s stock price plummeted 15% in a single session—losing $11.35 per share to close at $64.33 on unusually heavy trading volume on July 15, 2026.

“We are closely examining the timing of these disclosures, the sudden departure of the CFO after only four months, and the severe impact of channel destocking on Pentair’s financial health,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation of the alleged claims.

What Affected PNR Investors Should Do

If you purchased or acquired Pentair common stock between March 11, 2025, and July 14, 2026, and suffered significant financial losses, you have until October 2, 2026, to ask the court to appoint you as lead plaintiff.

To learn more about your legal options, submit your information to Hagens Berman, visit www.hbsslaw.com/pnr, call Reed Kathrein at 844-916-0895, or email [email protected]

If you’d like more information and answers to other frequently asked questions about the Pentair case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Pentair should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]



CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) — Hagens Berman Sobol Shapiro LLP—a national plaintiffs’ rights law firm with a premier securities practice group—notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This alert follows the U.S. Food and Drug Administration’s (FDA) recent decision to extend the review period for Capricor’s Biologics License Application (BLA), underscoring the ongoing regulatory and disclosure scrutiny surrounding the company.

Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now.

FDA Extends BLA Review Following Post-AdCom Submissions

On Aug. 24, Capricor announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) target action date for Capricor’s lead investigational cell therapy, deramiocel, for the treatment of Duchenne muscular dystrophy (DMD), moving the decision date from August 22, 2026, to November 22, 2026.

The agency classified Capricor’s recent submission—which follows a turbulent July 2026 Advisory Committee meeting and includes 24-month open-label extension data from the Phase 3 HOPE-3 study alongside a request to pivot toward a refined indication focused solely on upper limb function—as a major amendment.

Securities Class Action Details & Overview

View our latest video summary of the allegations: youtu.be/-lnVTKgV6as

Core Allegations and Background

  • Material Misleading Statements Regarding Clinical Trial Data and SAP Changes: The lawsuit alleges that Capricor and certain executives made materially false and misleading statements regarding the clinical trial data and regulatory pathway for its lead product candidate, Deramiocel, intended to treat Duchenne muscular dystrophy (DMD). Specifically, defendants allegedly failed to disclose that they adopted changes to the pre-specified statistical analysis plan (SAP) without agreement from the U.S. Food and Drug Administration (FDA) prior to resubmitting its Biologics License Application (BLA).

  • The HOPE-3 Trial Breakthrough and Subsequent Capital Raise: On December 3, 2025 Capricor announced “Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy.” The company’s CEO said “HOPE-3 delivered strong and definitive evidence that Deramiocel can meaningfully improve the course of Duchenne muscular dystrophy, demonstrating statistically significant improvements in both skeletal and cardiac function.” Driven by these claims, Capricor’s share price surged 370% to close up $23.60 on December 3, 2025. The following day, the company launched a public stock offering of approximately 6 million shares priced at $25 per share.

  • FDA Briefing Document Reveals SAP Changes and Triggers 64% Stock Collapse: Capricor’s public assurances unraveled on July 27, 2026, when the FDA published briefing documents ahead of an Advisory Committee meeting. The documents revealed that Capricor made unagreed-upon post-hoc modifications to its pre-specified Statistical Analysis Plan (SAP). The FDA stated that the HOPE-3 study “did not meet its pre-specified primary and secondary efficacy endpoints showing no statistically significant difference between deramiocel and placebo at 12 months.” Capricor shares crashed roughly 64% in a single day to close at $7.00. An Advisory Committee subsequently voted 9–3 against the efficacy of the drug, compounding investor losses.

Hagens Berman’s Investigation

“We’re focused on investors’ losses and uncovering the full scope of how management characterized these trial endpoints and undisclosed modification,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation on the claims alleged in the pending suit.

What Affected CAPR Investors Should Do

If you purchased or acquired Capricor securities between December 17, 2025, and July 26, 2026, and suffered significant financial losses, you have until September 28, 2026, to ask the court to appoint you as lead plaintiff. You do not need to seek lead plaintiff status to share in any potential recovery.

To learn more about your legal options, submit your information to Hagens Berman, visit www.hbsslaw.com/capr, call Reed Kathrein at 844-916-0895, or email [email protected].

If you’d like more information and answers to frequently asked questions about the Capricor case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Capricor should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]



INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) — Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts. The lawsuit seeks to represent investors who purchased or otherwise acquired PROCEPT common stock between February 28, 2024 and February 25, 2026.

National shareholders rights firm Hagens Berman is investigating legal claims that PROCEPT and the other Defendants violated the federal securities laws in their communications about sales of the company’s single-use handpiece, a component of its proprietary Aquablation therapy used to treat patients with an enlarged prostate.

The firm encourages investors who suffered substantial losses to submit your losses now. Persons with knowledge who may be able to assist the investigation are invited to contact the firm’s attorneys.

View our latest video summary of the allegations: youtu.be/N5u0rLr0QmA

Class Period: Feb. 28, 2024 – Feb. 25, 2026
Lead Plaintiff Deadline: Sept. 22, 2026
Visit:www.hbsslaw.com/prct
Contact the Firm Now: [email protected]
                                        844-916-0895

PROCEPT BioRobotics (PRCT) Securities Class Action:

The lawsuit alleges that during the Class Period, the defendants withheld crucial information from investors about PROCEPT’s business, operations, and financial condition. Its focus is on the propriety of the company’s statements and omissions related to handpiece sales practices in the U.S., including repeated touting of growth in those sales.

More specifically, the complaint alleges that (unknown to investors) the wrongdoing consisted of company’s utilization of an extensive discount program to incentivize its customers to place bulk orders exceeding customers’ procedures demands, pulling forward sales at the expense of future periods and, thereby, artificially inflating reported unit sales and revenues.

Investors began to learn the truth through a series of partial disclosures, each of which drove the price of PROCEPT shares sharply lower.

On August 6, 2025, PROCEPT announced its Q2 2025 financial results, revealing that the company’s handpiece sales unexpectedly deteriorated, missing consensus estimates by a wide margin.

Then, on November 4, 2025 PROCEPT reported its Q3 2025 results, again missing expected handpiece unit sales. During the corresponding earnings call, management slashed annual handpiece unit sales guidance to allow for the “optimization of field inventory[,]” and said PROCEPT had not “been managing customer inventory[,]” adding that some customers were “probably carrying too much.”

Finally, on February 25, 2026 PROCEPT announced Q4 2025 results. For the first time, the company disclosed the actual number of procedures in the field and revealed that U.S. handpiece sales materially exceeded procedures in each quarter since Q1 2023.

Of concern was that cumulative excess customer inventory of handpieces were over 10,000 units and U.S. handpiece sales sequentially cratered by 30%. Management then said that the company was eliminating its (previously undisclosed) bulk order discount program which was designed to incentivize customers to make large purchases during “the final weeks” of every quarter. The problem was the bulk order discount program essentially ate into future sales as customers already had excess inventories.  

As a result of these events, by February 25, the price of PROCEPT shares had steadily declined by $22.06, or over 48% from the close on August 6, 2025.

“We’re focused on whether PROCEPT may have intentionally pulled-in sales from future quarters to make it seem like the company was meeting expectations and, if so, whether the company had been sufficiently transparent in its investor communications,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in PROCEPT and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to other frequently asked questions about the PROCEPT case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding PROCEPT should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]



AppLovin (NASDAQ: APP) Faces Securities Class Action Amid Concerns Over Model Improvements — HBSS

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) — AppLovin Corporation (NASDAQ: APP) faces a securities class action seeking to represent investors who purchased or otherwise acquired AppLovin securities between February 12, 2026 and August 5, 2026.

The suit follows the publication of a concerning analyst report on July 13, 2026 and the company’s August 5, 2026 Q2 2026 financial results, each of which drove the price of AppLovin shares sharply lower.

The developments have prompted national shareholders rights firm Hagens Berman to open an investigation into claims that AppLovin violated the securities laws and urge AppLovin investors who suffered substantial losses to submit your losses now.  

Class Period: Feb. 12, 2026 – Aug. 5, 2026
Lead Plaintiff Deadline: Nov. 16, 2026
Visit:www.hbsslaw.com/app
Direct Contact Email: [email protected]
Firm Telephone: 844-916-0895

AppLovin Corporation (APP) Securities Class Action:

AppLovin provides end-to-end AI-powered advertising solutions for businesses to reach, monetize, and grow their global audience.

To investors, “uplift” is possibly the most critical driver of the company’s revenue growth. The company improves its AI model to increase uplift, better matching the exact right ad to the exact right user at the exact right millisecond. In turn, this uplifts advertisers’ return on ad spend, increases their advertising budgets, and (for AppLovin) accelerates high-margin revenue.

The lawsuit is focused on the propriety of AppLovin’s statements about model improvements and uplift.

Most recently, several weeks into AppLovin’s Q2, during its May 6, 2026 Q1 2026 earnings call, management left investors with high expectations for uplift and revenue growth.

CEO Adam Foroughi said that the most important milestone investors should focus on was the company’s “improving the underlying model.” He emphasized that “[l]ast quarter earnings, I mentioned we just had one new model that had just created an uplift[]” and “[t]he one we had a couple of weeks ago was quite substantial.” He also explained, “that’s why I highlighted […] that we saw a big acceleration going exiting the quarter[,]” and “then, April Q2, bigger than any quarter that we had[.]”

Investors’ expectations began to unravel on July 13, 2026, when a prominent analyst published a report highlighting a lack of immediate advertiser influx following the general availability launch of AppLovin’s advertising tools. In response, the price of AppLovin shares tumbled $64.13 (-12.6%).

Then, on August 5, 2026, the company reported its Q2 2026 revenue that was below midpoint. In apparent contrast to the “big acceleration,” management said “[o]ur pace of meaningful model improvement was lighter than normal during the quarter[]” and “we didn’t get the same level of model uplift we’ve seen in recent quarters[.]” This news drove the price of AppLovin shares crashing another $82.13 (-19.6%).

Between the two drops, the company lost over $44 billion of its market capitalization.

“We’re focused on when during Q2 AppLovin first knew that the uplift and revenue acceleration investors had come to expect wasn’t happening,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in AppLovin and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding AppLovin should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

Contact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, [email protected]